The disparity in capital allocation has reached a tipping point. While 32 rounds were logged, the gravity of a single $1B seed round has created a massive gap between AI and the rest of the ecosystem.
This concentration puts immense pressure on non-AI sectors. With $1.1B flowing into 16 AI rounds, the stakes are clear: software-led AI is out-raising hardware and specialized tech by an order of magnitude.
The Capital Divide
AI dominates the window, accounting for $1.1B of the $2.4B total disclosed. However, the distribution is top-heavy. The contrast is most stark when compared to the hardware and infrastructure sectors, which are facing a significant capital drought.
- AI: $1.1B across 16 rounds
- Health: $517M across 3 rounds
- Climate & Energy: $50M (1 round)
- Defense: $10M (1 round)
- Semiconductors: $5M (1 round)
- Robotics: $0K (1 round)
Biggest rounds
- Year-old AI lab Flapping Airplanes: $1B
- Oxford spin-out OMass Therapeutics: €275 million
- Pigment: $250m
- Cell-Specific RNA Delivery Firm Soufflé: $135M
- Nouscom: €120 million
What founders can do
- Pivot to AI-Integration: For those in robotics or semiconductors, framing the value proposition around AI enablement may help capture the current capital surge.
- Target Sector-Specific Funds: With Health securing $517M in just three rounds, founders in biotech should target specialized investors like Jefferson Life Sciences.
- Validate Early: The $1B seed for Flapping Airplanes suggests that investors are willing to take massive bets on AI labs if the technical promise is high enough.